A detailed history of Patton Albertson Miller Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 5,900 shares of NVO stock, worth $660,505. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,900
Previous 5,980 1.34%
Holding current value
$660,505
Previous $767,000 9.78%
% of portfolio
0.12%
Previous 0.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$122.71 - $146.91 $9,816 - $11,752
-80 Reduced 1.34%
5,900 $842,000
Q1 2024

Apr 24, 2024

SELL
$102.11 - $135.92 $20,422 - $27,183
-200 Reduced 3.24%
5,980 $767,000
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $17,556 - $21,090
-200 Reduced 3.13%
6,180 $639,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $276,457 - $606,601
3,040 Added 91.02%
6,380 $580,000
Q2 2023

Jul 13, 2023

SELL
$155.98 - $172.65 $74,246 - $82,181
-476 Reduced 12.47%
3,340 $540,000
Q1 2023

Apr 21, 2023

SELL
$132.34 - $159.14 $136,839 - $164,550
-1,034 Reduced 21.32%
3,816 $607,000
Q4 2022

Jan 23, 2023

SELL
$102.55 - $135.33 $28,201 - $37,215
-275 Reduced 5.37%
4,850 $0
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $51,620 - $60,905
-500 Reduced 8.89%
5,125 $571,000
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $41,895 - $50,643
-450 Reduced 7.41%
5,625 $625,000
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $15,340 - $18,732
-160 Reduced 2.57%
6,075 $680,000
Q3 2021

Oct 27, 2021

SELL
$84.42 - $106.62 $98,349 - $124,212
-1,165 Reduced 15.74%
6,235 $599,000
Q2 2021

Jul 29, 2021

SELL
$67.66 - $84.76 $25,372 - $31,785
-375 Reduced 4.82%
7,400 $620,000
Q1 2021

Apr 21, 2021

SELL
$67.06 - $75.82 $27,964 - $31,616
-417 Reduced 5.09%
7,775 $524,000
Q4 2020

Feb 25, 2021

SELL
$63.89 - $73.8 $5,302 - $6,125
-83 Reduced 1.0%
8,192 $615,000
Q1 2020

May 22, 2020

SELL
$49.46 - $64.78 $38,331 - $50,204
-775 Reduced 8.56%
8,275 $498,000
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $1,949 - $2,190
-41 Reduced 0.45%
9,050 $468,000
Q2 2019

Aug 12, 2019

BUY
$46.79 - $52.47 $425,367 - $477,004
9,091 New
9,091 $457,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Patton Albertson Miller Group, LLC Portfolio

Follow Patton Albertson Miller Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.